Donafenib suppresses glioblastoma progression: potential enhancement of therapeutic response in TMZ-resistant models.
Saved in:
| Title: | Donafenib suppresses glioblastoma progression: potential enhancement of therapeutic response in TMZ-resistant models. |
|---|---|
| Authors: | Yazici E; Department of Histology and Embryology, Faculty of Medicine, Akdeniz University, Antalya, Türkiye., Gezen A; Department of Histology and Embryology, Faculty of Medicine, Akdeniz University, Antalya, Türkiye., Kalay M; Department of Histology and Embryology, Faculty of Medicine, Akdeniz University, Antalya, Türkiye., Kocak O; Department of Biology, Institute of Sciences, Akdeniz University, Antalya, Türkiye., Oylumlu E; Department of Histology and Embryology, Faculty of Medicine, Akdeniz University, Antalya, Türkiye., Simsek E; Department of Nutrition and Dietetics, Institute of Health Sciences, Akdeniz University, Antalya, Türkiye.; Department of Medical Biotechnology, Institute of Health Sciences, Akdeniz University, Antalya, Türkiye., Tanriover G; Department of Histology and Embryology, Faculty of Medicine, Akdeniz University, Antalya, Türkiye. gamzetanriover@akdeniz.edu.tr.; Department of Medical Biotechnology, Institute of Health Sciences, Akdeniz University, Antalya, Türkiye. gamzetanriover@akdeniz.edu.tr. |
| Source: | Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2026 Jul 06. Date of Electronic Publication: 2026 Jul 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
